The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2

Susanne Krasemann, Undine Haferkamp, Susanne Pfefferle, +37

Stem Cell Reports

Targeting the Main Protease of SARS‐CoV‐2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors

Julian Breidenbach, Carina Lemke, Thanigaimalai Pillaiyar, +17

Angewandte Chemie International Edition

The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue

Melissa Zimniak, Luisa Kirschner, Helen Hilpert, +7

Scientific Reports

Selection and Validation of siRNAs Preventing Uptake and Replication of SARS-CoV-2

Maik Friedrich, Gabriele Pfeifer, Stefanie Binder, +14

Frontiers in Bioengineering and Biotechnology

Viral ReplicationSia1 ApplicationViral PathogenesisImmunologyAntiviral Drug +16

The Acid Ceramidase Is a SARS-CoV-2 Host Factor

Nina Geiger, Louise Kersting, Jan Schlegel, +12

Cells

Acetylsalicylic Acid and Salicylic Acid Inhibit SARS-CoV-2 Replication in Precision-Cut Lung Slices

Nina Geiger, Eva‐Maria König, Heike Oberwinkler, +8

Vaccines

Metabolite Salicylic AcidLung InflammationImmunologyCell Culture CellsAntiviral Drug +15

Cell Type-Specific Anti-Viral Effects of Novel SARS-CoV-2 Main Protease Inhibitors

Nina Geiger, Viktoria Diesendorf, Valeria Roll, +8

International Journal of Molecular Sciences

Protease InhibitorsViral ReplicationMedicineImmunologyAntiviral Drug Development +10

Korupensamine A, but not its atropisomer, korupensamine B, inhibits SARS-CoV-2 in vitro by targeting its main protease (Mpro)

Ahmed M. Sayed, Alyaa Hatem Ibrahim, Nasir Tajuddeen, +6

European Journal of Medicinal Chemistry

MedicineImmunologyAntiviral Drug DevelopmentAntiviral TherapyVirology +6

Drug-induced phospholipidosis is not correlated with the inhibition of SARS-CoV-2 - inhibition of SARS-CoV-2 is cell line-specific

Viktoria Diesendorf, Valeria Roll, Nina Geiger, +4

Frontiers in Cellular and Infection Microbiology

Acetylsalicylic acid and Salicylic acid inhibit SARS-CoV-2 replication in precision-cut lung slices

Nina Geiger, Eva‐Maria König, Heike Oberwinkler, +8